Investigation of magnesium aluminometasilicate (Neusilin US2) based surface solid dispersion of sorafenib tosylate using QbD approach: In vitro and in vivo pharmacokinetic study
Background and purpose: Sorafenib tosylate (SFN), a potent multikinase inhibitor, is used for the treatment of various cancers. However, it shows limited therapeutic applications due to its poor biopharmaceutical properties. The aim of the present investigation is to develop surface solid dispersion...
Saved in:
Main Authors: | Bijoy Kumar Panda (Author), Bothiraja Chellampillai (Author), Sharad Ghodke (Author), Ashwin Mali (Author), Ravindra Kamble (Author) |
---|---|
Format: | Book |
Published: |
International Association of Physical Chemists (IAPC),
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
by: Nawaf Almotairi, et al.
Published: (2022) -
Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix
by: Yang Guo, et al.
Published: (2017) -
Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation
by: Gabriela Wiergowska, et al.
Published: (2021) -
Sorafenib tosylate for advanced kidney cancer: lucky loser and magic box at the same time
by: Camillo Porta
Published: (2011) -
Applications of quality by design (QbD) and its tools in drug delivery
by: Lan Zhang, et al.
Published: (2016)